Skip to main content
Premium Trial:

Request an Annual Quote

Coastal Genomics Licenses Liquid Handling Tech for DNA Sample Prep

NEW YORK (GenomeWeb News) – Coastal Genomics announced that it has licensed from the BC Cancer Agency exclusive rights to a liquid handling automation technology.

The Vancouver, British Columbia-based firm said that the technology would be marketed as the Ranger automated workstation. The system, the company said, will be able to completely automate the process of agarose gel size selection of DNA fragments for between one and 96 samples in a single run.

The BC Cancer Agency's Genome Sciences Centre has been using the technology in house since 2010 and has processed more than 9,000 samples.

"The Ranger automated workstation has greatly improved sample preparation at the BCCA Genome Sciences Centre," Andy Mungall, the centre's library core group leader, said in a statement. "It's cost competitive with other methods and provides high quality output — we have been able to efficiently prepare thousands of samples for several major projects."

Coastal Genomics said that it plans to commercialize the technology this coming summer.

Financial and other terms of the license were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more